GB5005 CART

Phase 1Cell therapy

TThe First Affiliated Hospital of Xiamen University

GB5005 CART is one of 41 small molecule programs targeting Treatment. It is currently in Phase 1.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

TreatmentRecruiting

TreatmentPhase 1

Recruiting

Competition

Competitive Landscape

332 competitors in Treatment

#DrugCompanyPhaseTrials

Dexilant

Takeda

Preclinical

2 2

Alfenta

Jazz Pharmaceuticals

Preclinical

1 3

Niclocide

Bayer

Preclinical

1 4

Hivid

CConrado Roberto Hoffmann Filho

Preclinical

6 5

Valium

Akero Therapeutics

Preclinical

2 6

Clomid

Ferring

Preclinical

1 7

Aurlumyn

BBTG International Inc.

Preclinical

1 8

Lotemax

PPharmos

Preclinical

1 9

Norpramin

VValidus Pharmaceuticals

Preclinical

1 10

Barhemsys

Tibotec Pharmaceuticals, Ireland

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q2 2027

Phase 1Recruiting

Treatment

NCT06875063

Clinical

Trials by Indication[1]

Treatment1 trial

GB5005 CART-cell Injection in the Treatment of Patients With CD19-positive RR B-NHL

Recruiting·TThe First Affiliated Hospital of Xiamen University·Phase 1·NCT06875063·45 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for GB5005 CART. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — GB5005 CART compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for GB5005 CART. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — The First Affiliated Hospital of Xiamen University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Cell therapy[2]
Highest Phase: Phase 1[1]
Company: TThe First Affiliated Hospital of Xiamen University

GB5005 CART

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q2 2027

Trials by Indication[1]

Treatment1 trial

References

Drug Info

Quick Facts

Related News